96 related articles for article (PubMed ID: 11980362)
1. Growth of human glioblastomas as xenografts in the brains of athymic rats.
Ozawa T; Wang J; Hu LJ; Bollen AW; Lamborn KR; Deen DF
In Vivo; 2002; 16(1):55-60. PubMed ID: 11980362
[TBL] [Abstract][Full Text] [Related]
2. Characterization of human glioblastoma xenograft growth in athymic mice.
Ozawa T; Wang J; Hu LJ; Lamborn KR; Bollen AW; Deen DF
In Vivo; 1998; 12(4):369-74. PubMed ID: 9706486
[TBL] [Abstract][Full Text] [Related]
3. Establishment of a human glioblastoma stemlike brainstem rodent tumor model.
Siu IM; Tyler BM; Chen JX; Eberhart CG; Thomale UW; Olivi A; Jallo GI; Riggins GJ; Gallia GL
J Neurosurg Pediatr; 2010 Jul; 6(1):92-7. PubMed ID: 20593994
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effects of specific telomerase inhibitor GRN163 in human glioblastoma xenografts.
Ozawa T; Gryaznov SM; Hu LJ; Pongracz K; Santos RA; Bollen AW; Lamborn KR; Deen DF
Neuro Oncol; 2004 Jul; 6(3):218-26. PubMed ID: 15279714
[TBL] [Abstract][Full Text] [Related]
5. Why are systemic glioblastoma metastases rare? Systemic and cerebral growth of mouse glioblastoma.
Mourad PD; Farrell L; Stamps LD; Chicoine MR; Silbergeld DL
Surg Neurol; 2005 Jun; 63(6):511-9; discussion 519. PubMed ID: 15936366
[TBL] [Abstract][Full Text] [Related]
6. Experimental model and immunohistochemical comparison of U87 human glioblastoma cell xenografts on the chicken chorioallantoic membrane and in rat brains.
Strojnik T; Kavalar R; Barone TA; Plunkett RJ
Anticancer Res; 2010 Dec; 30(12):4851-60. PubMed ID: 21187462
[TBL] [Abstract][Full Text] [Related]
7. Response of intracerebral human glioblastoma xenografts to multifraction radiation exposures.
Ozawa T; Faddegon BA; Hu LJ; Bollen AW; Lamborn KR; Deen DF
Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):263-70. PubMed ID: 16904526
[TBL] [Abstract][Full Text] [Related]
8. Histological characteristics and expression of acidic and basic fibroblast growth factor genes in intracerebral xenogeneic transplants of human glioma cells.
Finkelstein SD; Black P; Nowak TP; Hand CM; Christensen S; Finch PW
Neurosurgery; 1994 Jan; 34(1):136-43. PubMed ID: 7510050
[TBL] [Abstract][Full Text] [Related]
9. The antitumor effects of Angelica sinensis on malignant brain tumors in vitro and in vivo.
Tsai NM; Lin SZ; Lee CC; Chen SP; Su HC; Chang WL; Harn HJ
Clin Cancer Res; 2005 May; 11(9):3475-84. PubMed ID: 15867250
[TBL] [Abstract][Full Text] [Related]
10. Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression.
Candolfi M; Curtin JF; Nichols WS; Muhammad AG; King GD; Pluhar GE; McNiel EA; Ohlfest JR; Freese AB; Moore PF; Lerner J; Lowenstein PR; Castro MG
J Neurooncol; 2007 Nov; 85(2):133-48. PubMed ID: 17874037
[TBL] [Abstract][Full Text] [Related]
11. Effect of human skin-derived stem cells on vessel architecture, tumor growth, and tumor invasion in brain tumor animal models.
Pisati F; Belicchi M; Acerbi F; Marchesi C; Giussani C; Gavina M; Javerzat S; Hagedorn M; Carrabba G; Lucini V; Gaini SM; Bresolin N; Bello L; Bikfalvi A; Torrente Y
Cancer Res; 2007 Apr; 67(7):3054-63. PubMed ID: 17409412
[TBL] [Abstract][Full Text] [Related]
12. Animal model of intramedullary spinal cord glioma using human glioblastoma multiforme neurospheres.
Hsu W; Siu IM; Pradilla G; Gokaslan ZL; Jallo GI; Gallia GL
J Neurosurg Spine; 2012 Mar; 16(3):315-9. PubMed ID: 22195609
[TBL] [Abstract][Full Text] [Related]
13. Effects of Matrigel on the SF-767 malignant glioma athymic mouse tumor model.
Wyrick BJ; Ozawa T; Lamborn KR; Bollen AW; Deen DF
Anticancer Res; 1997; 17(4A):2419-25. PubMed ID: 9252657
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo evaluations of the tyrosine kinase inhibitor NSC 680410 against human leukemia and glioblastoma cell lines.
Avramis IA; Christodoulopoulos G; Suzuki A; Laug WE; Gonzalez-Gomez I; McNamara G; Sausville EA; Avramis VI
Cancer Chemother Pharmacol; 2002 Dec; 50(6):479-89. PubMed ID: 12451475
[TBL] [Abstract][Full Text] [Related]
15. Human glioblastoma cells display mesenchymal stem cell features and form intracranial tumors in immunocompetent rats.
Nakahata AM; Suzuki DE; Rodini CO; Pereira MC; Janjoppi L; Okamoto OK
J Stem Cells; 2010; 5(3):103-11. PubMed ID: 22314826
[TBL] [Abstract][Full Text] [Related]
16. [Inhibition of angiogenesis and growth of malignant gliomas in the athymic nude rat model: immunotherapy against "basic fibroblast growth factor"].
Nemati MN; Stan AC; Pütz KM; Pietsch T; Walter GF; Dietz H
Zentralbl Neurochir; 1996; 57(1):12-9. PubMed ID: 8900894
[TBL] [Abstract][Full Text] [Related]
17. Experimental model and immunohistochemical analyses of U87 human glioblastoma cell xenografts in immunosuppressed rat brains.
Strojnik T; Kavalar R; Lah TT
Anticancer Res; 2006; 26(4B):2887-900. PubMed ID: 16886610
[TBL] [Abstract][Full Text] [Related]
18. Quantitative comparison between the transplantability of human and murine tumors into the subcutaneous tissue of NCr/Sed-nu/nu nude and severe combined immunodeficient mice.
Taghian A; Budach W; Zietman A; Freeman J; Gioioso D; Ruka W; Suit HD
Cancer Res; 1993 Oct; 53(20):5012-7. PubMed ID: 8402692
[TBL] [Abstract][Full Text] [Related]
19. Somatostatin analogues and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of human glioblastomas in vitro and in vivo.
Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K
Cancer Res; 1994 Nov; 54(22):5895-901. PubMed ID: 7954420
[TBL] [Abstract][Full Text] [Related]
20. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
Ning S; Knox SJ
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
